Stallion India Fluorochemicals Limited has announced the resignation of its Independent Director, Shri Gautam Lath, effective April 20, 2026. The resignation was communicated to the National Stock Exchange of India Limited and BSE Limited on April 21, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Details

Shri Gautam Lath (DIN: 10198794) submitted his resignation letter dated April 20, 2026, citing "increasing professional commitments" as the reason for his departure. The resignation became effective from the same date as the letter submission.

Board Committee Impact

Consequent to his resignation, Lath has stepped down from all Board committees of the company where he served as either Chairman or Member. This change affects the overall composition of the company's Board and its various committees.

Regulatory Compliance

The company has fulfilled all regulatory requirements under SEBI LODR Regulations. As part of the disclosure requirements, Stallion India Fluorochemicals confirmed that:

• The resignation letter with detailed reasons has been enclosed with the regulatory filing
• Lath holds no directorships in other listed entities
• No other material reasons exist for the resignation beyond those mentioned in the resignation letter

Company Confirmation

In his resignation letter, Gautam Lath confirmed that he has no claims against the company and expressed gratitude to the Board of Directors for their support during his tenure. The company's filing was signed by Govind Rao, Company Secretary & Compliance Officer (Mem No.: A47094), ensuring proper documentation and regulatory compliance.

The resignation represents a routine corporate governance matter, with the company maintaining transparency through appropriate regulatory disclosures to both stock exchanges.

Stallion India Fluorochemicals has witnessed a significant stake increase by Neomile Asset Managers Pvt. Ltd. and its associated fund, as disclosed in a regulatory filing under SEBI's substantial acquisition regulations. The acquisition represents a notable expansion of the asset manager's position in the fluorochemicals company.

Acquisition Details

Neomile Asset Managers Pvt. Ltd., along with Neomile Growth Fund – Series I, acquired 1,04,39,203 shares of Stallion India Fluorochemicals Limited between March 4-6, 2026. The acquisition was executed through a combination of rights issue participation and open market purchases.

Shareholding Changes

The transaction resulted in a substantial increase in Neomile's stake in the fluorochemicals company. Prior to this acquisition, the combined entities held a modest position in Stallion India Fluorochemicals.

Company Capital Structure Impact

The acquisition coincided with changes in Stallion India Fluorochemicals' capital structure, likely due to the rights issue component of the transaction. The company's equity share capital expanded significantly during this period.

Regulatory Compliance

The disclosure was made in compliance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. The filing was submitted to both NSE (scrip code: STALLION) and BSE (scrip code: 544342) on March 6, 2026.

Neomile Asset Managers and Neomile Growth Fund – Series I are not part of the promoter or promoter group of Stallion India Fluorochemicals Limited. The acquisition represents a strategic investment by the asset management firm in the fluorochemicals sector.

Market Presence

Stallion India Fluorochemicals Limited maintains its listing on both the National Stock Exchange of India Limited and Bombay Stock Exchange Limited. The company operates from its registered office in Mumbai's Malad West area and continues to be actively traded on both exchanges following this significant shareholding change.